Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shixue Dai
Observed names:
S X Dai,
Shi-Xue Dai,
Shi-xue Dai,
Shi‐Xue Dai,
shixue dai
Institutions:
Ganzhou People's Hospital,
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University
Observed institutions:
Sun Yat-sen University,
East Carolina University,
Guangdong General Hospital,
Ganzhou People's Hospital,
Nanfang Hospital,
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University,
South China University of Technology
show all 9
ORCID:
0000-0001-6428-3634
Observed ORCID:
0000-0001-6428-3634
OpenAlex ID:
A5041338087
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
2020
·
Yu-chen Cao
, Qi-xin Deng
, et al.
·
Travel Medicine and Infectious Disease
·
321
PDF
Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology
2020
·
Chen Yang
, Xiaowen Huang
, et al.
·
Briefings in Bioinformatics
·
308
Is a low FODMAP diet beneficial for patients with inflammatory bowel disease? A meta-analysis and systematic review
2017
·
Yong-le Zhan
, Yong-an Zhan
, et al.
·
Clinical Nutrition
·
113
Risk of skin cancers in thiopurines‐treated and thiopurines‐untreated patients with inflammatory bowel disease: A systematic review and meta‐analysis
2018
·
Shao‐Zhuo Huang
, Zhi‐Cheng Liu
, et al.
·
Journal of Gastroenterology and Hepatology
·
64
Tumor Necrosis Factor Alpha Blocking Agents as Treatment for Ulcerative Colitis Intolerant or Refractory to Conventional Medical Therapy: A Meta-Analysis
2014
·
Ruxi Lv
, Weiguang Qiao
, et al.
·
PLoS ONE
·
52
PDF
Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy
2019
·
Zili Lin
, Huiyi Wu
, et al.
·
Inflammatory Bowel Diseases
·
41
Dysbiosis of intestinal microbiota to predict in-hospital mortality in critically ill patients: results of a prospective observational cohort study
2020
·
Ru Wei
, Xu Chen
, et al.
·
32
PDF
CD8+CD28+/CD8+CD28− T cell equilibrium can predict the active stage for patients with inflammatory bowel disease
2017
·
Shi-xue Dai
, Hong-xiang Gu
, et al.
·
Clinics and Research in Hepatology and Gastroenterology
·
29
Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Anti-tumour Necrosis Factor Alpha Agents: A Systematic Review and Meta-analysis
2018
·
Chen Yang
, Junlin Huang
, et al.
·
Journal of Crohn s and Colitis
·
28
Comparison and recommendation of dietary patterns based on nutrients for Eastern and Western patients with inflammatory bowel disease
2023
·
Yue Hou
, Sai-Feng Wang
, et al.
·
Frontiers in Nutrition
·
27
PDF
Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?
2018
·
Ze-Feng Zhang
, Yu-Jun Luo
, et al.
·
World Journal of Clinical Cases
·
24
PDF
New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease
2022
·
Qi-Qi Li
, Hui-Hong Zhang
, et al.
·
Frontiers in Pediatrics
·
19
PDF
Environmental and Microbial Factors in Inflammatory Bowel Disease Model Establishment: A Review Partly through Mendelian Randomization
2023
·
Zesheng Lin
, Wenjing Luo
, et al.
·
Gut and Liver
·
18
PDF
Balance of CD8+CD28+/CD8+CD28− T Lymphocytes Is Vital for Patients with Ulcerative Colitis
2012
·
Shi-Xue Dai
, Gang Wu
, et al.
·
Digestive Diseases and Sciences
·
16
CD4+CD29+T cells are blamed for the persistent inflammatory response in ulcerative colitis.
2015
·
Yuzhen Zhu
, Yanling Feng
, et al.
·
PubMed
·
14
Comment on ‘Meta-Analysis of the Association Between Anti-Tumour Necrosis Factor Use and Lymphoma Risk in Patients With Inflammatory Bowel Disease: Methodological Considerations’
2018
·
Chen Yang
, Xiaowen Huang
, et al.
·
Journal of Crohn s and Colitis
·
13
Decreased CD8+CD28+/CD8+CD28– T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease
2017
·
Shi-xue Dai
, Hong-xiang Gu
, et al.
·
Medicine
·
12
From dysbiosis to precision therapy: decoding the gut-bladder axis in bladder carcinogenesis
2025
·
Ze-qiang Liu
, Xiao-ying Yang
, et al.
·
Frontiers in Oncology
·
9
PDF
Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota
2023
·
Jia-qi Xu
, Yu-ke Pan
, et al.
·
Frontiers in Medicine
·
9
PDF
The effects and predictive value of calcium and magnesium concentrations on nutritional improvement, inflammatory response and diagnosis in patients with Crohn's disease
2023
·
Ying Zheng
, Yijun Liao
, et al.
·
Journal of Human Nutrition and Dietetics
·
9
PDF
Artificial liver research output and citations from 2004 to 2017: a bibliometric analysis
2019
·
Yan Li
, Meizhi He
, et al.
·
PeerJ
·
7
Protective mechanism of Bifidobacterium on intestinal mucosal barrier in sepsis
2025
·
Kai-jun Zhang
, Yi-feng Chang
, et al.
·
Microbial Pathogenesis
·
6
Causal relationship between asthma and ulcerative colitis and the mediating role of interleukin-18: a bidirectional Mendelian study and mediation analysis
2023
·
Xin Zou
, Rui-Ling Lu
, et al.
·
Frontiers in Immunology
·
6
[Huangqin decoction lowers the number of mast cells in ulcerative colitis in rats with dampness and heat syndrome].
2011
·
Xue-bao Zheng
, Hong-bo Liu
, et al.
·
PubMed
·
4
Genetic architecture of primary sclerosing cholangitis: shared pathways with inflammatory bowel disease and gut–liver axis mediation
2025
·
Yu Chen
, Hui-Hong Zhang
, et al.
·
International Journal of Surgery
·
3
Show more works
View as search
Works count:
46
Citation count:
1,201
H-index:
14
I10-index:
17
Year
Topic
Type